Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MedtFine Blood Lancet

K-Number: K221383 · 2022-09-21

Decision Date2022-09-21
Product CodeQRK
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

MedtFine Blood Lancet is a medical device manufactured by Shanghai Carelife International Trading Co. , Ltd.. It received FDA 510(k) clearance on 2022-09-21 under approval number K221383. The device is classified under product code QRK. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MedtFine Blood Lancet?

MedtFine Blood Lancet is a medical device that received FDA 510(k) clearance on 2022-09-21. It is manufactured by Shanghai Carelife International Trading Co. , Ltd.. The 510(k) number is K221383.

When was MedtFine Blood Lancet approved by the FDA?

MedtFine Blood Lancet received FDA 510(k) clearance on 2022-09-21, under approval number K221383.

What company makes MedtFine Blood Lancet?

MedtFine Blood Lancet is manufactured by Shanghai Carelife International Trading Co. , Ltd..

What is the FDA product code for MedtFine Blood Lancet?

The FDA product code for MedtFine Blood Lancet is QRK.

Related Devices (Code: QRK)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.